Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

9D2P

PANK3 complex structure with compound PZ-4127

9D2P の概要
エントリーDOI10.2210/pdb9d2p/pdb
分子名称Pantothenate kinase 3, 2-(4-{2-[4-(6-chloropyridazin-3-yl)piperazin-1-yl]-2-oxoethyl}anilino)-2-oxoethyl acetate, ACETIC ACID, ... (7 entities in total)
機能のキーワードpank, substrate, complex, transferase, pantothenate kinase, inhibitor, activator
由来する生物種Homo sapiens (human)
タンパク質・核酸の鎖数1
化学式量合計43131.25
構造登録者
Yun, M.,Lee, R.E. (登録日: 2024-08-09, 公開日: 2025-08-13, 最終更新日: 2026-04-22)
主引用文献Coker, A.L.,Tangallapally, R.,Yun, M.K.,Subramanian, C.,Jayasinghe, T.,Miller, K.,Edwards, A.,Frank, M.,Jackowski, S.,Rock, C.O.,White, S.W.,Lee, R.E.
Discovery of Sulfonamide Pantothenate Kinase Activators and Elucidation of the Role of Isoform Selectivity in Cellular Pantothenate Kinase Activation.
J.Med.Chem., 69:6004-6013, 2026
Cited by
PubMed Abstract: Coenzyme A (CoA) biosynthesis is controlled by the four isoforms of the rate-limiting enzyme pantothenate kinase (PANK), whose tissue expression and subcellular localization regulate CoA homeostasis. Pantazines are positive allosteric modulators of PANK that increase cellular CoA levels by disrupting feedback inhibition by acyl-CoA esters. In this study, a structure-guided design was used to modify the Pantazine scaffold near the ATP-binding site to address metabolic liabilities of earlier leads. Replacement of a metabolically labile cyclopropyl group with a sulfonamide introduced a new hydrogen-bonding interaction with the γ-phosphate of ATP in the PANK3•ATP•Pantazine complex. This interaction improved ligand affinity, solubility, and metabolic stability. Analysis of isoform-specific inhibition revealed that cellular CoA elevation correlates with the difference in affinity between PANK3 and PANK1β, defining an "activation window" for CoA induction. Lead sulfonamide Pantazines were metabolically stable and increased hepatic CoA levels, supporting their potential for treating metabolic CoA deficiencies.
PubMed: 41771535
DOI: 10.1021/acs.jmedchem.5c03452
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (1.8 Å)
構造検証レポート
Validation report summary of 9d2p
検証レポート(詳細版)ダウンロードをダウンロード

252456

件を2026-04-22に公開中

PDB statisticsPDBj update infoContact PDBjnumon